hotspot -WSS

hotspot

author：leisure time 2025-09-28 02:28:01 - browse：8622

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： AI can decode, harness the power of the humane immune system

explore

WSS

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Physician executives need more than on

Obesity now affects over 1 billion people worldwide, study finds

What to expect at HLTH 2023, the health care industry conference

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

focus

hotspot

hotspot

Supreme Court strikes down use of affirmative action

Liquid biopsy for lung cancer is launched by Delfi

After affirmative action ruling, medical educators look to 'holistic review'

Why getting cancer drugs just got harder for rural patients

Moonlake's readout produced a cash windfall. Risks remain

Colorectal cancer study finds potential in overlooked immune cell

Hepatitis C has a cure — but many Americans still lack access to it

Why getting cancer drugs just got harder for rural patients

Trump demands the U.S. pay no more for drugs than other countries … again

AstraZeneca loses challenge to Medicare drug price negotiation

hotspot

Obesity now affects over 1 billion people worldwide, study finds

ALS groups 'won't be played again' by the FDA, drug sponsors

FDA does about

3 questions for the future of Biden's cancer moonshot

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Flu vaccine offering decent levels of protection this winter, new data show

knowledge

focus

explore

focus